Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2021-10-22 00:00:00 ET · period of report 2021-10-20 · accession 0001567619-21-018627 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-22 | 2021-10-20+ | TMCI | Treace John T. | CEO, Dir, 10% | S - Sale | $21.54 | -165.0K | 5.75M | -3% | -$3.55M |
| I | 2021-10-22 | 2021-09-07 | TMCI | Treace John T. | CEO, Dir, 10% | A - Grant | $0.00 | +408.8K | 408.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-22 | S | D | 57,534 | $20.74 | 5,753,135 | D | — | — | (F9) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.12 to $21.03 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-09-07 | A | A | 408,816 | $0.00 | 408,816 | I | — | — | |
| 3 | Common | Common Stock | 2021-10-20 | S | D | 22,612 | $24.79 | 5,894,968 | D As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021 | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.21 to $25.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F12) The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee. |
| 4 | Common | Common Stock | 2021-10-21 | S | D | 39 | $24.50 | 5,810,669 | D | — | — | |
| 5 | Common | Common Stock | 2021-10-21 | S | D | 4,044 | $23.86 | 5,810,708 | D | — | — | (F8) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.38 to $24.25 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2021-10-21 | S | D | 8,207 | $23.07 | 5,814,752 | D | — | — | (F7) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.37 to $23.36 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2021-10-21 | S | D | 2,768 | $21.49 | 5,822,959 | D | — | — | (F6) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.98 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2021-10-21 | S | D | 26,701 | $20.67 | 5,825,727 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.22 to $21.16 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2021-10-21 | S | D | 34,325 | $19.89 | 5,852,428 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.21 to $20.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2021-10-20 | S | D | 8,215 | $25.37 | 5,886,753 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.22 to $25.69 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 11 | Common | Common Stock | 2021-10-22 | S | D | 555 | $21.16 | 5,752,580 | D | — | — | (F10) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.14 to $21.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |